These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 27108935)

  • 81. 2-Amino-6-chloro-3,4-dihydroquinazoline: A novel 5-HT3 receptor antagonist with antidepressant character.
    Dukat M; Alix K; Worsham J; Khatri S; Schulte MK
    Bioorg Med Chem Lett; 2013 Nov; 23(21):5945-8. PubMed ID: 24035337
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Piperazine analogs of naphthyridine-3-carboxamides and indole-2-carboxamides: novel 5-HT3 receptor antagonists with antidepressant-like activity.
    Dhar AK; Mahesh R; Jindal A; Bhatt S
    Arch Pharm (Weinheim); 2015 Jan; 348(1):34-45. PubMed ID: 25581677
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Generation of an agonistic binding site for blockers of the M(3) muscarinic acetylcholine receptor.
    Thor D; Schulz A; Hermsdorf T; Schöneberg T
    Biochem J; 2008 May; 412(1):103-12. PubMed ID: 18237275
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Atropine- and scopolamine-resistant subtypes of muscarinic receptors in the rabbit aorta.
    Manjeet S; Sim MK
    Eur J Pharmacol; 1989 Dec; 174(1):99-105. PubMed ID: 2612581
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Prolonged inhibition of 5-HT₃ receptors by palonosetron results from surface receptor inhibition rather than inducing receptor internalization.
    Hothersall JD; Moffat C; Connolly CN
    Br J Pharmacol; 2013 Jul; 169(6):1252-62. PubMed ID: 23581504
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Molecular mechanism of setron-mediated inhibition of full-length 5-HT
    Basak S; Gicheru Y; Kapoor A; Mayer ML; Filizola M; Chakrapani S
    Nat Commun; 2019 Jul; 10(1):3225. PubMed ID: 31324772
    [TBL] [Abstract][Full Text] [Related]  

  • 87. 5-HT3 receptors.
    Thompson AJ; Lummis SC
    Curr Pharm Des; 2006; 12(28):3615-30. PubMed ID: 17073663
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Comparison of the effects of a selective muscarinic receptor antagonist and hyoscine (scopolamine) on motion sickness, skin conductance and heart rate.
    Golding JF; Stott JR
    Br J Clin Pharmacol; 1997 Jun; 43(6):633-7. PubMed ID: 9205824
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Theoretical evaluation of antiemetic effects of 5-HT3 receptor antagonists for prevention of vomiting induced by cisplatin.
    Nakamura H; Yokoyama H; Takayanagi R; Yoshimoto K; Nakajima A; Okuyama K; Iwase O; Yamada Y
    Eur J Drug Metab Pharmacokinet; 2015 Mar; 40(1):39-44. PubMed ID: 24470169
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Allosteric modulation of 5-HT3 serotonin receptors.
    Maksay G; Bíró T; Bugovics G
    Eur J Pharmacol; 2005 May; 514(1):17-24. PubMed ID: 15878320
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Antispasmodic action of propinox on the isolated human gallbladder: possible mechanism of action.
    Baistrocchi RL; Orti E; de los Santos AR; Di Girolamo G; Marti ML; Pico JC
    Acta Physiol Pharmacol Ther Latinoam; 1999; 49(3):161-9. PubMed ID: 10797855
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Multiple 5-HT receptors in the guinea-pig superior cervical ganglion.
    Watkins CJ; Newberry NR
    Br J Pharmacol; 1996 Jan; 117(1):21-8. PubMed ID: 8825338
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Effects of 5-HT2B, 5-HT3 and 5-HT4 receptor antagonists on gastrointestinal motor activity in dogs.
    Morita H; Mochiki E; Takahashi N; Kawamura K; Watanabe A; Sutou T; Ogawa A; Yanai M; Ogata K; Fujii T; Ohno T; Tsutsumi S; Asao T; Kuwano H
    World J Gastroenterol; 2013 Oct; 19(39):6604-12. PubMed ID: 24151388
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Influence of sodium substitutes on 5-HT-mediated effects at mouse 5-HT3 receptors.
    Barann M; Schmidt K; Göthert M; Urban BW; Bönisch H
    Br J Pharmacol; 2004 Jun; 142(3):501-8. PubMed ID: 15148263
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The diverse actions of volatile and gaseous anesthetics on human-cloned 5-hydroxytryptamine3 receptors expressed in Xenopus oocytes.
    Suzuki T; Koyama H; Sugimoto M; Uchida I; Mashimo T
    Anesthesiology; 2002 Mar; 96(3):699-704. PubMed ID: 11873047
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Differential affinities of AF-DX 116, atropine and pirenzepine for muscarinic receptors of guinea pig gastric fundus, atria and urinary bladder: might atropine distinguish among muscarinic receptor subtypes?
    Del Tacca M; Danesi R; Blandizzi C; Bernardini MC
    Pharmacology; 1990; 40(5):241-9. PubMed ID: 1980366
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Species difference in the 5-hydroxytryptamine3 receptor associated with the von Bezold-Jarisch reflex.
    Yamano M; Ito H; Kamato T; Miyata K
    Arch Int Pharmacodyn Ther; 1995; 330(2):177-89. PubMed ID: 8861711
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Mapping spatial relationships between residues in the ligand-binding domain of the 5-HT3 receptor using a molecular ruler.
    Nyce HL; Stober ST; Abrams CF; White MM
    Biophys J; 2010 May; 98(9):1847-55. PubMed ID: 20441748
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Characterizing new fluorescent tools for studying 5-HT₃ receptor pharmacology.
    Jack T; Simonin J; Ruepp MD; Thompson AJ; Gertsch J; Lochner M
    Neuropharmacology; 2015 Mar; 90():63-73. PubMed ID: 25460187
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Structural basis of ligand recognition in 5-HT3 receptors.
    Kesters D; Thompson AJ; Brams M; van Elk R; Spurny R; Geitmann M; Villalgordo JM; Guskov A; Danielson UH; Lummis SC; Smit AB; Ulens C
    EMBO Rep; 2013 Jan; 14(1):49-56. PubMed ID: 23196367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.